Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Dec 7, 2022--
The "RNAi Technology Market, By Application, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
RNA based therapeutics have garnered significant attention in recent years due to its potential to treat a variety of disease such as cardiovascular disease, cancer, diabetes, TB, AIDS, as well as rare and genetic disorders. RNAi also has the potential to treat viral diseases such as those caused by the human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Moreover, RNAi is now being used in biological and biomedical research to study the effect of blocking expression of a given gene.
Market Dynamics:
Increasing prevalence of chronic diseases, rise in focus on RNAi therapeutic development, rise in number of applications in molecular diagnostics, frequent approvals of RNAi therapeutics, and the outbreak of COVID-19 are major factors expected to drive growth of the global RNAi technology market over the forecast period.
For instance, in June 2022, Alnylam Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) approved AMVUTTRA, an RNAi therapeutic administered via subcutaneous injection once every three months for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults. Moreover, in August 2018, The U.S. Food and Drug Administration (FDA) approved Alnylam Pharmaceuticals' Onpattro, an RNAi therapeutic for individuals with a rare and deadly genetic disorder called hereditary transthyretin-mediated amyloidosis.
Key features of the study:
Detailed Segmentation:
Global RNAi Technology Market, By Application:
Global RNAi Technology Market, By Geography:
Company Profiles:
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global RNAi Technology Market - Impact of Coronavirus (Covid-19) Pandemic
5. Global RNAi Technology Market, By Application, 2017-2028, (US$ Mn)
6. Global RNAi Technology Market, By Geography, 2017-2028, (US$ Mn)
7. Competitive Landscape
8. Section
For more information about this report visit https://www.researchandmarkets.com/r/diyx6g
View source version on businesswire.com:https://www.businesswire.com/news/home/20221207005621/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: BIOTECHNOLOGY GENETICS HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/07/2022 10:42 AM/DISC: 12/07/2022 10:43 AM
http://www.businesswire.com/news/home/20221207005621/en